A Scientific Study at the University of Basrah Reveals a Novel Treatment Derived from Camel Blood Plasma
A research team from the College of Veterinary Medicine at University of Basrah, comprising Dr. Numeir Abdul Karim Khudair, Dr. Muhannad Fares Abdulhamid, and master’s student Hussein Radi Ta’mah, has published a scientific study titled “Camel Plasma: An Innovative Treatment for Colibacillosis in Lambs.”
The study, published in Veterinary World—a Scopus-indexed journal ranked in the first quartile (Q1)—investigated the use of camel blood plasma as a novel therapeutic approach for treating Escherichia coli (E. coli) infection in newborn lambs. It also compared the efficacy of camel plasma with conventional treatments, including antibiotics, camel milk, and commercial probiotics, with the aim of promoting sustainable livestock production and reducing the incidence of zoonotic diseases.
The findings demonstrated a notable therapeutic advantage, as camel plasma showed superior effectiveness in improving clinical symptoms and modulating inflammatory responses compared to conventional methods. Additionally, it contributed significantly to enhancing passive immunity in infected lambs and offered a non-antibiotic intervention to combat microbial infections, thereby helping to mitigate the growing problem of antimicrobial resistance (AMR).
Department of Media and Government Communication
